AtonRa Partners’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | $425K | Sell |
8,396
-933
| -10% | -$47.2K | 0.85% | 49 |
|
2023
Q3 | $423K | Sell |
9,329
-2,307
| -20% | -$105K | 0.89% | 40 |
|
2023
Q2 | $477K | Sell |
11,636
-708
| -6% | -$29K | 0.74% | 63 |
|
2023
Q1 | $441K | Sell |
12,344
-1,531
| -11% | -$54.7K | 0.64% | 73 |
|
2022
Q4 | $524K | Sell |
13,875
-3,753
| -21% | -$142K | 0.67% | 66 |
|
2022
Q3 | $780K | Sell |
17,628
-518
| -3% | -$22.9K | 0.77% | 56 |
|
2022
Q2 | $672K | Buy |
+18,146
| New | +$672K | 0.62% | 75 |
|
2021
Q2 | – | Sell |
-20,146
| Closed | -$906K | – | 115 |
|
2021
Q1 | $906K | Buy |
20,146
+12,329
| +158% | +$554K | 0.4% | 94 |
|
2020
Q4 | $442K | Buy |
+7,817
| New | +$442K | 0.22% | 103 |
|